GeneBioPharma

GeneBioPharma is a specialty pharmaceutical and biotechnology company headquartered in Princeton, New Jersey, with a focus on developing innovative therapies for oncology, neurology, and metabolic disorders. The company utilizes a dual strategy, developing both New Chemical Entities (NCEs) and Value-Added Medicines through the 505(b)(2) regulatory pathway to improve patient outcomes. GeneBioPharma's pipeline includes candidates targeting solid tumors, neuropathic pain, and metabolic conditions like NASH and diabetes. By leveraging its expertise in drug delivery and formulation, the company aims to enhance the efficacy and safety profiles of existing treatments while advancing novel discovery programs. GeneBioPharma maintains a global presence with research and development operations in India to support its clinical advancement.